Review of a Proposed Mechanism for the Antinociceptive Action of Botulinum Toxin Type A

This publication has 50 references indexed in Scilit:

• Botulinum toxin type A in prophylactic treatment of migraine headaches: a preliminary study
  The Journal of Headache and Pain, 2003
• Single‐Site Botulinum Toxin Type A Injection for Elimination of Migraine Trigger Points
  Headache: The Journal of Head and Face Pain, 2003
• Botulinum Toxin Type A as an Effective Prophylactic Treatment in Primary Headache Disorders
  Headache: The Journal of Head and Face Pain, 2003
• Botulinum toxin A and the cutaneous nociception in humans: A prospective, double-blind, placebo-controlled, randomized study
  Journal of the Neurological Sciences, 2002
• Differential contribution of the two phases of the formalin test to the pattern of c- fos expression in the rat spinal cord: studies with remifentanil and lidocaine
  Pain, 1997
• Ketoprofen produces profound inhibition of spinal c-Fos protein expression resulting from an inflammatory stimulus but not from noxious heat
  Pain, 1996
• Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm
  Movement Disorders, 1987
• Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis.
  The Journal of cell biology, 1986
• Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves.
  The Journal of cell biology, 1986
• Tetanus toxin and botulinum A toxin inhibit release and uptake of various transmitters, as studied with particulate preparations from rat brain and spinal cord
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1981